In this article, financial journalist Marc Davis discusses the mass production of psychedelic pharmaceuticals and the steep educational curve facing medical science. Medical science is on the cusp of making some extraordinary evidence-based breakthroughs in addressing the pandemic-induced global mental health crisis. This is thanks to the advent of a novel new class of pharmaceutical [ ]
The post The case for mass producing psychedelic pharmaceuticals appeared first on Health Europa.
Friday 5 March 2021
Latest News
